Skip to main content

. 1997 Aug;73(862):519–520. doi: 10.1136/pgmj.73.862.519

Nitrofurantoin rechallenge and recurrent toxicity.

M C Bialas ¹, H G Shetty ¹, J Houghton ¹, F Woods ¹, P A Routledge ¹

PMCID: PMC2431384 PMID: 9307751

519

Images in this article

Figure
on p.520

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

D'Arcy P. F. Nitrofurantoin. Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):540–547. doi: 10.1177/106002808501900706. [DOI] [PubMed] [Google Scholar]
Hebert M. F., Roberts J. P. Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother. 1993 Oct;27(10):1193–1194. doi: 10.1177/106002809302701007. [DOI] [PubMed] [Google Scholar]
Iwarson S., Lindberg J., Lundin P. Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases. Scand J Gastroenterol. 1979;14(4):497–502. [PubMed] [Google Scholar]
Paiva L. A., Wright P. J., Koff R. S. Long-term hepatic memory for hypersensitivity to nitrofurantoin. Am J Gastroenterol. 1992 Jul;87(7):891–893. [PubMed] [Google Scholar]
Robinson B. W. Nitrofurantoin-induced interstitial pulmonary fibrosis. Presentation and outcome. Med J Aust. 1983 Jan 22;1(2):72–76. [PubMed] [Google Scholar]
Yiannikas C., Pollard J. D., McLeod J. G. Nitrofurantoin neuropathy. Aust N Z J Med. 1981 Aug;11(4):400–405. doi: 10.1111/j.1445-5994.1981.tb03521.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES